119 studies found for:    Open Studies | niaid
Show Display Options
Rank Status Study
21 Recruiting Retrospective Multicenter Study to Determine 4-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-05 Study
Condition: Cardiac Transplantation
Intervention:
22 Recruiting Eosinophilic Esophagitis Databank
Conditions: Esophagitis;   Eosinophilic Esophagitis
Intervention:
23 Recruiting High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals
Conditions: Cryptococcal Meningitis;   HIV Infections
Interventions: Drug: Fluconazole;   Drug: Amphotericin B
24 Recruiting Validation of Gene Expression Markers of Renal Allograft Functional Decline
Condition: Kidney Transplantation
Intervention:
25 Recruiting Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children
Conditions: Heart Transplant;   Liver Transplant;   Small Intestine Transplant;   Lymphoproliferative Disorders;   Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorder
Interventions: Procedure: transplant;   Drug: Immunosuppressive Drugs
26 Recruiting Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis
Condition: Secondary Progressive Multiple Sclerosis
Interventions: Procedure: Blood Draw;   Procedure: CSF collection by lumbar puncture (Optional)
27 Recruiting Impact of Vaccination on Th2 Immunity in Infancy
Condition: Food Hypersensitivity
Interventions: Procedure: Skin prick allergen test;   Procedure: Blood draw
28 Recruiting Evaluating the Safety and Tolerability of Etravirine in HIV-1 Infected Infants and Children
Condition: HIV Infections
Intervention: Drug: Etravirine (ETR)
29 Recruiting Evaluating the Safety and Immune Response to Three Different DNA HIV Vaccines Administered With a MVA-CMDR Boost Vaccine in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: DNA Nat-B env;   Biological: DNA CON-S env;   Biological: DNA Mosaic env;   Biological: MVA-CMDR;   Biological: Placebo for DNA Nat-B env;   Biological: Placebo for DNA CON-S env;   Biological: Placebo for DNA Mosaic env;   Biological: Placebo for MVA-CMDR
30 Recruiting Evaluating the Safety, Tolerability, and Pharmacokinetics of an Investigational, Injectable HIV Medicine (GSK1265744) in HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Drug: GSK1265744 Tablets;   Drug: Injectable GSK1265744;   Drug: Placebo for GSK1265744 Tablets;   Drug: Injectable Placebo for GSK1265744
31 Recruiting Evaluation of the Safety and Efficacy of a Single Dose of a Dengue Vaccine (TV005) in Healthy Adults
Condition: Dengue
Interventions: Biological: TV005;   Biological: Placebo;   Biological: rDEN2∆30-7169
32 Recruiting Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
Conditions: Systemic Lupus Erythematosus;   SLE
Interventions: Drug: Mycophenolate Mofetil;   Drug: Hydroxychloroquine or Chloroquine;   Drug: Prednisone
33 Recruiting Evaluating the Safety and Pharmacokinetics of Raltegravir in Infants
Condition: HIV Infections
Intervention: Drug: Raltegravir
34 Recruiting Evaluating the Safety and Drug Levels of an Antibody Against HIV in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: VRC01;   Biological: SC placebo for VRC01;   Biological: IV placebo for VRC01
35 Recruiting Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications
Condition: Influenza
Interventions: Drug: Amantadine, Ribavirin, Oseltamivir;   Drug: Oseltamivir
36 Recruiting Evaluating the Safety and Efficacy of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) in Adults Hospitalized With Influenza
Conditions: Influenza A;   Influenza B
Interventions: Biological: Intravenous hyperimmune immunoglobulin (IVIG);   Biological: Placebo for IVIG
37 Recruiting Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in Infants and Children
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV ΔNS2 Δ1313 I1314L Vaccine;   Biological: Placebo (1x Leibovitz L-15 medium)
38 Recruiting Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
Condition: Colitis, Ulcerative
Interventions: Biological: Trichuris suis ova (TSO);   Biological: Placebo
39 Unknown  Safety of an Oral HIV Vaccine in HIV Uninfected Volunteers
Condition: HIV Infections
Intervention: Biological: SCBaL/M9
40 Not yet recruiting Evaluating the Safety and Pharmacokinetics of VRC01, a Potent Anti-HIV Neutralizing Monoclonal Antibody, in HIV-1-Exposed Infants
Condition: HIV Infections
Intervention: Biological: VRC01

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years